a pbpk platform model to guide intravenous and subcutaneous dosing for bispecific t cell engagers
Published 2 months ago • 247 plays • Length 48:15Download video MP4
Download video MP3
Similar videos
-
59:49
pbpk modeling approaches to assess risks associated with bioequivalence in drug development
-
1:02:16
leveraging dermal pbpk modeling and simulation approaches
-
57:56
pbpk models for mabs in paediatrics and pregnancy – current status, opportunities and challenges
-
55:43
pbpk modelling to predict drug-biologic interactions with cytokine modulators
-
55:53
mechanistic model-informed discovery & development of bispecific antibodies for immuno-oncology
-
59:17
applications of pbpk modelling for regulatory submissions: case studies
-
1:02:46
solving a mystery using pbpk: how drug-excipient complexes can confound a metabolic ddi result
-
1:01:14
pbpk modeling & simulation to support asciminib nda submission and inform drug product label
-
1:06:27
the importance of pbpk model validation and reproducibility in obstetric pharmacology
-
58:36
pbpk for the pill an approach to assess the risk benefit of drugs
-
36:08
pbpk modeling of antibody-drug conjugates – concept and application
-
1:50
b·right – caixaimpulse validate 2018
-
10:03
cellport software
-
1:46
procellics™ raman analyzer with bio4c™ pat raman software
-
3:51
achieving a higher pcr rate with nab-paclitaxel in breast cancer
-
0:38
xpr precision balance smartpan ja
-
1:58
high throughput antibody production - qpix
-
1:00:40
what's new in pbpk & the simcyp simulator
-
39:17
an introduction to pbpk, simcyp discovery, and the simcyp product suite